We aim to make a difference in patient's lives by developing molecular tests to assess disease pathology, guide surgical decisions, and improve patient outcomes.
About Prolias Technologies
Prolias Technologies is an emerging molecular diagnostics company focusing on predictive and prognostic genetic cytology. Our novel molecular tests provide a definitive pathological diagnosis that allows more accurate utility of surgical procedures. more
